Cancergenetic and genomic research can never be completely accurate. Today’s cancergenetic and genomic research is all based off of predictions and can lead tofalse diagnoses and treatment plans, causing the patients and government a lotof money. This testing error is a result of the program’s lack of funding. Thisprevents researchers and specialist from perfecting and furthering their researchabout cancer and genetic knowledge. If new testing were to be implemented, thenew data may not be an exact guarantee, but testing and treatment plans arevery important because cancer is a growing disease and in order to save thelives of many people, risks are needed to be taken to ensure cancer genetic andgenomic research is accurate and reliable. In order to eliminate the problem ofinaccurate results and treatment options, the government would have to investmore money into the program to see what researchers are capable of doing.
With the constant need for cancergenetic and genomic research, cancer information needs to be more accurate, becausedoctors and specialist rely on this information to make diagnosis and treatmentplans for their patients. “The future projection of the newgenetic-molecular technologies in the field of diagnosis and precociousdetection is very limited by the lack of rigor in the research on these tests.These problems are at the root of the reiterated false expectations which arecreated around these diagnostic tests” (Lumbreras et al.).
A big obstacle in this field isthat researchers do not have proper equipment to perform all the test needed tomake a reliable conclusion. In order for a specialist or doctor to make aproper diagnosis, it is crucial for them to have data and studies to back uptheir speculations. Many researchersbase their diagnosis off of past research instead of up-to-date information becausethey do not have proper equipment. Relying on past information can be non-beneficialbecause it is not up-to-date and could hold false information that is no longeruseful anymore, or that has been proven to be wrong. In their article, Cornelland Val El discuss the barriers of performing new tests and research projectswithout sufficient funding.
These obstacles prevent researchers from conductingnew genome sequencing, forcing them to rely on previous testing to help diagnosetheir patients. “In cancer screening, genetic education, and economicevaluations, much work needs to be done for both the public health and geneticscommunities to address barriers and make use of promising developments tofurther a successful and responsible implementation of genetic services inpublic health” (Cornell and Van El). Diagnosingpatients based on old information can be very misleading and dangerous, becauseif a doctor diagnoses a patient that has the same symptoms and sequencing asanother patient thirty years ago, it does not mean that they have the samediseases. Having a constant flow of new data and tests can be very beneficial, becausedoctors can make more accurate diagnosis and create better treatment options. Having a well-known cause about aspecific research field is beneficial, because if people can understand theimportance of your research, the government would be more willing to invest init, thus helping their financial problems. Cancer genetics and genomics is nota well-known research project, but is essential because it monitors genemutations and comes up with potential treatment options before they get cancer.”Advances in genomic analysis technologies haveled to the development of new diagnostic tests with clinical application.Therefore, as in other diagnostic fields, awareness of the methodologicallimitations of genetic investigation will facilitate the application of theresults” (Lumbreras et al.
). Developing a researcher program can be very hardin the beginning, because the government may not want to invest in a new programdue to lack of experience and the fear it might not work out. The only way fora program to grow is to become well-know and prove they are worth being financiallysupported. As the program starts to become more advanced, cancer genetic andgenomic research becomes more reliable and can start to do what the program wasmade to do. “The advances derived from the HumanGenome Project have led to the development of new kinds of diagnostic tests,genetic, molecular or proteomic, which can be incorporated into clinicalpractice” (Lumbreras et al.). The medical field is advancing in many ways, inboth research or medical equipment. It is necessary for everyone in thesefields to have the proper equipment and recourses because it allows researchersto get more accurate and up-to-date results instead of reusing data that couldbe many years old.
In order for new research projects to succeed, the team mustexplain the importance of the research and have sufficient proposals to receivefunding. With a constant source of money, the research team can buy proper equipmentto effectively perform tests and cancer genome sequencing. Although cancergenetic and genomic research is not a well-known organization, it is a veryimportant field of study and with proper supplies and equipment, researchers canhelp improve the cancer genetic and genomic research organization. Being ableto predict accurate genome sequencing and treatment options are very important,because they can be very expensive and having to do multiple tests can resultit wrong information and expensive medical bills, but with proper governmentfunding, this could all be avoided. Genome testing is very expensive because itgoes through extensive research and lab work in order to read mutated DNA genesor potential cancer diseases. “Misinterpretation could lead to unnecessary andexpensive medical interventions or to neglect in undertaking properpreventative action” (Nordgren 63).
Using outdated equipment can result ininaccurate results and lead to many ethical and financial problems. Having sufficientfunding could help eliminate this problem and ultimately result in moreaccurate readings and data. “Onesingle process to sequence all of our genes of interest at the same timerepresents a major improvement in the laboratory organization by being lesstime- and personnel-consuming. This process can also be more efficient byproposing actionable gene analysis in addition to analysis of the principalgenes analyzed in the clinical setting” (Collet et al.). With more accurate readings, specialists can monitor gene abnormalities in orderto review the effects on the body for future studies and potential treatmentsoptions. Having proper equipment can lead to more accurate and reliabletesting, limiting the costs of false data and treatment plans. Being able to diagnose patients correctly is why governmentfunding is essential for the development of cancer genetic and genomic research,because it will provide the proper systems and equipment to make more accuratepredictions and treatment options.
A big controversy in this research fieldis if researches actually get funding, will testing work or will they still bestuck reproducing false and inaccurate information. Officials can never be sureabout genetic testing because if they are never given the chance to performtesting, then they will never know the answer. “This study also demonstratesthat data analysis remains a major issue. Geneticists must be actively involvedin data analysis based on a good understanding of bioinformatics pipelines toavoid reporting poor quality results” (Collet et al.
). Collet and her researchteam discuss the controversy between receiving funding and what they will be doingwith it. Her team talks about how researchers can do all these tests with newequipment, but they question whether researchers can actually understand theinformation and read it correctly. There is no point in spending thousands of dollarsand brand-new equipment when the people using it cannot even read the test results,because they do not have adequate knowledge about the equipment. Since governmentfunding has not worked in the first place, researchers need to create a new wayto raise awareness and money. In order for this field to be successful,researchers will have to take care of this problem themselves.
Manyorganizations that suffer financially often become desperate and try thingssuch as asking for more money or posting flyers around town, but that neverseems to work because there is no information or moral connections with it. Whenpeople donate money, it is often associated with something dealing with faithor self-values, creating a strong connection so they are willing to give moneyin order to help that organization. For example, “St. Jude’s institution raised more money than anyAmerican hospital, nearly $700 million last year.” (Barrett). Many people are drawntowards donating to St. Jude’s because their morals and self-values: feelingobligated to donate to help those in need. With cancer genetic and genomicresearch, if the public were to know more about this field and what researchersdo, society would most likely be willing to donate money since they would have abetter understanding about what they are trying to do.
Researchers could host a5k run because they usually draw in a lot of attention and would help raiseawareness about the organization. Other events researcher could host arecarnivals or benefit concerts because they bring in a lot of money and it givesother people a chance to have fun while learning about where the proceeds aregoing. In this case, the proceeds would be going to benefit the research programby purchasing up-to-date equipment in order to produce accurate data. Since many researchers have not had the luxury touse new equipment, no one can be confident that funding will be beneficial. Thispotential problem is due to the program’s lack of funding from the government. Workingwith old equipment and data prevents researchers and specialist from perfectingtheir research about cancer and genetic knowledge. In order to eliminate thisproblem, the cancer genetic and genomic research organization will have toraise money or receive more government funding so they to purchase up-to-date equipmentin pursuance of producing accurate and reliable data.
Although testing can have its flaws, risks are meantto be taken for the safety of patients and the future of medical research. Being able to diagnose patients correctly is why governmentfunding is essential for the development of cancer genetic and genomic research,because it will provide the proper systems and equipment to make more accuratepredictions and treatment options.